Cheminformatics and Bioinformatics at the Interface with Systems Biology
Kumar, Ajay (National Sun Yat-sen University, Taiwan), Sahi, Shakti (Gautam Buddha University, India), Nawab, Sadia (Shanghai Jiao Tong University, China), Wei, Dongqing (Shanghai Jiao Tong University, China), Mehmood, Aamir (Shanghai Jiao Tong University, China), Kaushik, Aman Chandra (Shanghai Jiao Tong University, China)The cost of drug development is increasing, and investment returns are decreasing. The number of drugs approved by FDA is in decline in terms of the number of new molecular entities (NMEs). Amongst the reasons noted for this are the adverse side effects and reduced efficiency of many of the potential compounds. This is a problem both for the pharmaceutical industry and for those suffering from dis...
The cost of drug development is increasing, and investment returns are decreasing. The number of drugs approved by FDA is in decline in terms of the number of new molecular entities (NMEs). Amongst the reasons noted for this are the adverse side effects and reduced efficiency of many of the potential compounds. This is a problem both for the pharmaceutical industry and for those suffering from dis...
